Learn the key differences between obstructive and nonobstructive HCM, including how your specific diagnosis can impact ...

Beta-blockers have been the initial treatment for symptomatic obstructive hypertrophic cardiomyopathy (HCM) despite limited evidence of their efficacy. Aficamten is a cardiac myosin inhibitor that ...